The Contrasting Effects of Dopamine and Norepinephrine on Systemic and Splanchnic Oxygen Utilization in Hyperdynamic Sepsis

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 17, 1994, Pages 1354-1357

  Marik, Paul E ^a   Mohedin, Mohammed ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NORADRENALIN;

ARTICLE; CALORIMETRY; HEMODYNAMICS; HUMAN; INFECTION RISK; INTENSIVE CARE; OXYGEN CONSUMPTION; OXYGEN TENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; STOMACH PH; TONOMETRY;

EID: 84942384304     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520170064037     Document Type: Article

References (30)

1. 1. Centers for Disease Control. Increase in national hospital discharge survey rates for septicemia— United States, 1979-1987. MMWR Morb Mortal Wkly Rep. 1990;39:31-34.
2. 2. Parillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227-242.
3. 3. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med. 1989;17:389-393.
4. 4. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994;120: 771-783.
5. 5. Parker MM, Parrillo JE. Septic shock: hemodynamics and pathogenesis. JAMA. 1983;250:3324-3327.
6. 6. Thijs LG. Peripheral circulation in human septic shock. Intensive Crit Care Digest. 1988;7:9-11.
7. 7. Sibbald WJ, Fox G, Martin CM. Abnormalities of vascular reactivity in sepsis syndrome. Chest. 1991;100(suppl):155S-159S.
8. 8. Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med. 1993;21: 1296-1303.
9. 9. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol. 1992; 73:1159-1164.
10. 10. Ensinger H, Weichel T, Lindner KH, Grunert A, Ahnefeld FW. Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers. Crit Care Med. 1993;21: 1502-1508.
11. 11. Schreuder WO, Schneider M, Groeneveld ABJ, Thijs LG. Effect of dopamine vs norepinephrine on hemodynamics in septic shock: emphasis on right ventricular performance. Chest. 1989;95:1282-1288.
12. 12. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for treatment of hyperdynamic septic shock. Chest. 1993;103:1826-1831.
13. 13. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med. 1989; 17:426-429.
14. 14. Lucas CE. A new look at dopamine and norepinephrine for hyperdynamic septic shock. Chest. 1994;105:7-8.
15. 15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
16. 16. Antonsson JB, Boye CC, Kruithoff KL, et al. Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol. 1990;259:G519-G523.
17. 17. Heard SO, Helmoortel CM, Kent JC, et al. Gastric tonometry in health volunteers: effects of ranitidine on calculated intramural pH. Crit Care Med. 1991;19:271-274.
18. 18. Ronco JJ, Phang PT. Validation of an indirect calorimeter to measure oxygen consumption in critically ill patients. J Crit Care. 1991;6:36-41.
19. 19. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest. 1988;94:1176-1186.
20. 20. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier D, Ocampo HA. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest. 1989;96:120-126.
21. 21. Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102: 216-220.
22. 22. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of noreprinephrine therapy in human septic shock. Crit Care Med. 1987;15:134-137.
23. 23. Bartlett RH, Dechert RE. Oxygen kinetics: pitfalls in clinical research. J Crit Care. 1990;5:77-80.
24. 24. Uusaro A, Ruokonen E, Takala J. Dopexamine induces gastric mucosal acidosis despite increased splanchnic blood flow after cardiac surgery. Crit Care Med. 1994:22:A70.
25. 25. Giraud GD, MacCannell KL. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther. 1984;2:30:214-220.
26. 26. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med. 1992;20:80-91.
27. 27. Vitek V, Cowley RA. Blood lactate in the prognosis of various forms of shock. Ann Surg. 1971; 173:308-313.
28. 28. Rosenberg JC, Rush BF. Blood lactic acid levels an irreversible hemorrhagic and lethal endotoxic shock. Surg Gynecol Obstet. 1968;126:1247-1250.
29. 29. Cowan BN, Burns HJG, Boyle P, Ledingham IMA. The relative prognostic value of lactate and hemodynamic measurement in early shock. Anaesthesia. 1984;39:750-755.
30. 30. Marshall JC, Christou NV, Horn R, Meakins JL. The microbiology of multiple organ failure: the proximal GI tract as an occult reservoir of pathogens. Arch Surg. 1988;123:309-315.